Management of the national performers list. 2.1. NHS England will continue to perform its primary medical care functions under the National Health Service (Performers Lists) (England) Regulations 2013.
Management of the national performers list. 2.1 Subject to Xxxxxxxxx 0.0, XXX Xxxxxxx will continue to perform its functions under the National Health Service (Performers Lists) (England) Regulations 2013.
Management of the national performers list. 2.1 Subject to Paragraph 2.2, NHS England will continue to perform its functions under the National Health Service (Performers Lists) (England) Regulations 2013.
2.2 The ICB will carry out administrative tasks in respect of the Performers Lists as described at:
2.2.1 Paragraph 9 of Part 2, Schedule 2A;
2.2.2 Paragraph 9 of Part 2, Schedule 2B; and
2.2.3 Paragraph 6 of Part 2, Schedule 2C.
2.3 NHS England’s functions in relation to the management of the national performers list include:
2.3.1 considering applications and decision-making in relation to inclusion on the national performers list, inclusion with conditions and refusals;
2.3.2 identifying, managing and supporting primary care performers where concerns arise; and
2.3.3 managing suspension, imposition of conditions and removal from the national performers list.
2.4 NHS England may hold local Performance Advisory Group (“PAG”) meetings to consider all complaints or concerns that are reported to NHS England in relation to a named performer and NHS England will determine whether an initial investigation is to be carried out.
2.5 NHS England may notify the ICB of all relevant PAG meetings at least seven (7) days in advance of such meetings. NHS England may require a representative of the ICB to attend such meetings to discuss any performer concerns and/or quality issues that may impact on individual performer cases.
2.6 The ICB must develop a mechanism to ensure that all complaints regarding any named performer are escalated to the Local NHS England Team for review. The ICB will comply with any Mandated Guidance issued by NHS England in relation to the escalation of complaints about a named performer.
Management of the national performers list. Subject to Paragraph 2.2, NHS England will continue to perform its functions under the National Health Service (Performers Lists) (England) Regulations 2013. The ICB will carry out administrative tasks in respect of the Performers Lists as described at: Paragraph 9 of Part 2, Schedule 2A; Paragraph 9 of Part 2, Schedule 2B; and Paragraph 6 of Part 2, Schedule 2C. NHS England’s functions in relation to the management of the national performers list include: considering applications and decision-making in relation to inclusion on the national performers list, inclusion with conditions and refusals; identifying, managing and supporting primary care performers where concerns arise; and managing suspension, imposition of conditions and removal from the national performers list. NHS England may hold local Performance Advisory Group (“PAG”) meetings to consider all complaints or concerns that are reported to NHS England in relation to a named performer and NHS England will determine whether an initial investigation is to be carried out. NHS England may notify the ICB of all relevant PAG meetings at least seven (7) days in advance of such meetings. NHS England may require a representative of the ICB to attend such meetings to discuss any performer concerns and/or quality issues that may impact on individual performer cases. The ICB must develop a mechanism to ensure that all complaints regarding any named performer are escalated to the Local NHS England Team for review. The ICB will comply with any Mandated Guidance issued by NHS England in relation to the escalation of complaints about a named performer. Management of the revalidation and appraisal process NHS England will continue to perform its functions under the Medical Profession (Responsible Officers) Regulations 2010 (as amended by the Medical Profession (Responsible Officers) (Amendment) Regulations 2013). All functions in relation to GP appraisal and revalidation will remain the responsibility of NHS England, including: the funding of GP appraisers; quality assurance of the GP appraisal process; and the responsible officer network. Funding to support the GP appraisal is incorporated within the global sum payment to Primary Medical Services Provider. The ICB must not remove or restrict the payments made to Primary Medical Services Provider in respect of GP appraisal. Appraisal arrangements in respect of all other primary care practitioner groups shall also be Reserved Functions.
